IRIDEX CORP Operating Lease, Right-of-Use Asset, Amortization Expense
IRIDEX CORP (IRIX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $548.00 thousand for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-18
- IRIDEX CORP operating lease, right-of-use asset, amortization expense for the quarter ending 2026-07-04 was $276.00K, a 9.96% increase year-over-year.
- IRIDEX CORP operating lease, right-of-use asset, amortization expense for the quarter ending 2026-04-04 was $272.00K, a 10.57% increase year-over-year.
- IRIDEX CORP operating lease, right-of-use asset, amortization expense for the quarter ending 2026-01-03 was $271.00K, a 11.98% increase year-over-year.
- IRIDEX CORP operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-27 was $256.00K, a 85.51% increase year-over-year.
- IRIDEX CORP operating lease, right-of-use asset, amortization expense for fiscal 2026 was $1.02M, a 21.90% increase from fiscal 2024.
- IRIDEX CORP operating lease, right-of-use asset, amortization expense for fiscal 2024 was $840.00K, a 10.06% decline from fiscal 2023.
- IRIDEX CORP operating lease, right-of-use asset, amortization expense for fiscal 2023 was $934.00K, a 3.89% increase from fiscal 2022.
- IRIDEX CORP operating lease, right-of-use asset, amortization expense for fiscal 2022 was $899.00K, a 0.66% decline from fiscal 2022.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-07-04 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-18 | $548.00K 10-Q · filed 2026-08-18 | $819.00K derived: sum of 3 quarters · filed 2026-08-18 | $1.07M derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-04-04 | $272.00K 10-Q · filed 2026-05-19 | $543.00K derived: sum of 2 quarters · filed 2026-05-19 | $799.00K derived: sum of 3 quarters · filed 2026-05-19 | $1.05M derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-01-03 | $271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-02 | $527.00K derived: sum of 2 quarters · filed 2026-04-02 | $778.00K derived: sum of 3 quarters · filed 2026-08-18 | $1.02M 10-K · filed 2026-04-02 |
| 2025-09-27 | $256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $507.00K derived: sum of 2 quarters · filed 2026-08-18 | $753.00K 10-Q · filed 2025-11-12 | $995.00K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-06-28 | $251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-18 | $497.00K 10-Q · filed 2026-08-18 | $739.00K derived: sum of 3 quarters · filed 2026-08-18 | $877.00K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-29 | $246.00K 10-Q · filed 2026-05-19 | $488.00K derived: sum of 2 quarters · filed 2026-05-19 | $626.00K derived: sum of 3 quarters · filed 2026-05-19 | $856.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-28 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-02 | $380.00K derived: sum of 2 quarters · filed 2026-04-02 | $610.00K derived: sum of 3 quarters · filed 2026-04-02 | $840.00K 10-K · filed 2026-04-02 |
| 2024-09-28 | $138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $368.00K derived: sum of 2 quarters · filed 2025-11-12 | $598.00K 10-Q · filed 2025-11-12 | $755.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-29 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $460.00K 10-Q · filed 2025-08-12 | $617.00K derived: sum of 3 quarters · filed 2025-08-12 | $867.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-30 | $230.00K 10-Q · filed 2025-05-13 | $387.00K derived: sum of 2 quarters · filed 2025-05-13 | $637.00K derived: sum of 3 quarters · filed 2025-05-13 | $922.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-30 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $407.00K derived: sum of 2 quarters · filed 2025-03-27 | $692.00K derived: sum of 3 quarters · filed 2025-03-27 | $934.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $535.00K derived: sum of 2 quarters · filed 2024-11-12 | $777.00K 10-Q · filed 2024-11-12 | $974.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-07-01 | $285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $527.00K 10-Q · filed 2024-08-08 | $724.00K derived: sum of 3 quarters · filed 2024-08-08 | $959.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-04-01 | $242.00K 10-Q · filed 2024-05-14 | $439.00K derived: sum of 2 quarters · filed 2024-05-14 | $674.00K derived: sum of 3 quarters · filed 2024-05-14 | $908.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $432.00K derived: sum of 2 quarters · filed 2024-03-29 | $666.00K derived: sum of 3 quarters · filed 2024-03-29 | $899.00K 10-K · filed 2024-03-29 |
| 2022-10-01 | $235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $469.00K derived: sum of 2 quarters · filed 2023-11-20 | $702.00K 10-Q · filed 2023-11-20 | |
| 2022-07-02 | $234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $467.00K 10-Q · filed 2023-08-10 | ||
| 2022-04-02 | $233.00K 10-Q · filed 2023-05-11 | |||
| 2022-01-01 | $905.00K 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |